Geriatric Issues in Ovarian Cancer

  • Miriam RodinEmail author


Older age is an independent prognostic indicator in ovarian cancer. Population data and case series over recent decades show poorer survival of older women regardless of stage. In Western countries, older women are less likely to receive the optimal surgery and standard chemotherapy established in clinical trials. However, in some series older women do well, and in some they do not tolerate standard of care if it is given. This chapter presents geriatric measures that may help in selecting which older women will be fit for standard surgical and medical therapy, geriatric management principles which modulate risk factors for adverse treatment effects, and direct supportive measures for older women with advanced disease.


Ovarian cancer Elderly patients Clinical oncology Operative ­mortality Chemotherapy 


  1. 1.
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda., based on Nov 2011 SEER data submission, posted to the SEER web site, April 2012.
  2. 2.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer Clin. 2009;59(4):1–25.Google Scholar
  3. 3.
  4. 4.
  5. 5.
    Langstraat C, Aletti GD, Cliby WA. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol. 2011;123(2):187–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Thrall MM, et al. Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol. 2011;118(3):537–47.PubMedCrossRefGoogle Scholar
  7. 7.
    Janda M, et al. Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer. 2008;18(5):896–907.PubMedCrossRefGoogle Scholar
  8. 8.
    Goff BA, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109(10):2031–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Hightower RD, et al. National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients. Cancer. 1994;73(2):377–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Gerestein CG, et al. Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review. Gynecol Oncol. 2009;114(3):523–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Alphs HH, et al. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol. 2006;103(3):1048–53.PubMedCrossRefGoogle Scholar
  12. 12.
    Ben-Ami I, et al. Perioperative morbidity and mortality of gynecological oncologic surgery in elderly women. Int J Gynecol Cancer. 2006;16(1):452–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Chereau E, et al. Ovarian cancer in the elderly: impact of surgery on morbidity and survival. Eur J Surg Oncol. 2011;37(6):537–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Giannice R, et al. Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer. 2001;92(10):2562–8.PubMedCrossRefGoogle Scholar
  15. 15.
    McLean KA, et al. Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction. Gynecol Oncol. 2010;118(1):43–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Wright J, et al. Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer. 2008;98(7):1197–203.PubMedCrossRefGoogle Scholar
  17. 17.
    Sharma S, et al. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol. 2005;193(6):2077–82.PubMedCrossRefGoogle Scholar
  18. 18.
    Fotopoulou C, et al. Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival. Int J Gynecol Cancer. 2010;20(1):34–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Diaz-Montes TP, et al. Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol. 2005;99(2):352–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Susini T, et al. Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. Int J Gynecol Cancer. 2007;17(3):581–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Maas HA, et al. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol. 2005;97(1):104–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Eisenhauer EL, et al. Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol Oncol. 2007;106(2):381–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Markman M, et al. Epithelial ovarian cancer in the elderly. The memorial Sloan-Kettering Cancer Center experience. Cancer. 1993;71(2 Suppl):634–7.PubMedGoogle Scholar
  24. 24.
    Edmonson JH, Su J, Krook JE. Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies. Cancer. 1993;71(2 Suppl):615–7.PubMedGoogle Scholar
  25. 25.
    Moore DH, et al. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;94(2):368–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Earle CC, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98(3):172–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Audisio RA, et al. Preoperative assessment of cancer in elderly patients: a pilot study. Support Cancer Ther. 2003;1(1):55–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Pope D, Ramesh H, Gennari R, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2007;15:189–97.CrossRefGoogle Scholar
  29. 29.
    Kristjansson SK, Farinella E, Gaskell S, Audisio RA. Surgical risk and post-operative complications in older unfit cancer patients. Cancer Treat Rev. 2009;35:499–502.PubMedCrossRefGoogle Scholar
  30. 30.
    Pignata S, et al. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Crit Rev Oncol Hematol. 2008;66(3):229–36.PubMedCrossRefGoogle Scholar
  31. 31.
    McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334:1–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Freyer G, Tinker AV, I. Gynecologic Cancer. Clinical trials and treatment of the elderly diagnosed with ovarian cancer. Int J Gynecol Cancer. 2011;21(4):776–81.PubMedCrossRefGoogle Scholar
  33. 33.
    Markman M, Petersen J, Montgomery R. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer. 2006;107(4):849–53.PubMedCrossRefGoogle Scholar
  34. 34.
    Hershman D, et al. Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study. Gynecol Oncol. 2004;92(1):293–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Hershman D, et al. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol. 2004;94(2):540–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Hilpert F, et al. Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged > or = 70 years with advanced ovarian cancer – a study by the AGO OVAR Germany. Ann Oncol. 2007;18(2):282–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Kothari R, et al. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer. Gynecol Oncol. 2010;119(3):491–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Freyer G, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol. 2005;16(11):1795–800.PubMedCrossRefGoogle Scholar
  39. 39.
    Tredan O, et al. Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens. Ann Oncol. 2007;18(2):256–62.PubMedCrossRefGoogle Scholar
  40. 40.
    Uyar D, et al. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. Gynecol Oncol. 2005;98(3):403–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Moore KN, et al. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol. 2008;110(2):133–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Steer CB. Chemotherapy for ovarian cancer in the older adult. Curr Treat Options Oncol. 2009;10(3–4):159–70.PubMedCrossRefGoogle Scholar
  43. 43.
    Nurgalieva Z, Liu C-C, Du XL. Risk of hospitalizations associated with adverse effects of ­chemotherapy in a large community-based cohort of elderly women with ovarian cancer. Int J Gynecol Cancer. 2009;19(8):1314–21.PubMedCrossRefGoogle Scholar
  44. 44.
    Lichtman SM, et al. International society of geriatric oncology chemotherapy taskforce: evaluation of chemotherapy in older patients – an analysis of the medical literature. J Clin Oncol. 2007;25(14):1832–43.PubMedCrossRefGoogle Scholar
  45. 45.
    Bonetti A, et al. Cisplatin pharmacokinetics in elderly patients. Ther Drug Monit. 1994;16(5):477–82.PubMedCrossRefGoogle Scholar
  46. 46.
    Tew WP, Lichtman SM. Ovarian cancer in older women. Semin Oncol. 2008;35(6):582–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Hurria A, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65.PubMedCrossRefGoogle Scholar
  48. 48.
    NCCN Clinical Practice Guidelines Senior Adult Oncology Guidelines v.2. 2012.
  49. 49.
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.PubMedCrossRefGoogle Scholar
  50. 50.
    Balducci L. Aging, frailty and chemotherapy. Cancer Control. 2007;14:7–12.PubMedGoogle Scholar
  51. 51.
    Olde Rikkert MGM, et al. Geriatric syndromes: medical misnomer or progress in geriatrics? Neth J Med. 2003;61(3):83–7.PubMedGoogle Scholar
  52. 52.
    Repetto L, Fratino L, Audisio R, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRefGoogle Scholar
  53. 53.
    Lipsitz LA. Dynamic models for the study of frailty. Mech Ageing Dev. 2008;129(11):675–6.PubMedCrossRefGoogle Scholar
  54. 54.
    O’Mahony R, et al. Synopsis of the National Institute for Health and Clinical Excellence guideline for prevention of delirium. Ann Intern Med. 2011;154(11):746–51.PubMedGoogle Scholar
  55. 55.
    Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.PubMedCrossRefGoogle Scholar
  56. 56.
    Luciani A, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.PubMedCrossRefGoogle Scholar
  57. 57.
    Hurria A, Hurria E, Zuckerman E, et al. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc. 2006;54:1119–24.PubMedCrossRefGoogle Scholar
  58. 58.
    Overcash JA, Beckstead J, Moody L, et al. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006;59(3):205–10.PubMedCrossRefGoogle Scholar
  59. 59.
    Extermann M, et al. MAX2 – a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer. 2004;40(8):1193–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Capone LJ, et al. Characteristics of hospitalized cancer patients who fall. J Nurs Care Qual. 2010;25(3):216–23.PubMedCrossRefGoogle Scholar
  61. 61.
    Bylow K, Dale W, Mustian K, et al. Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology. 2008;72(2):422–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Rodin MB, Gupta SJ. A practical approach to geriatric assessment in oncology. J Clin Oncol. 2007;25(14):1936–44.PubMedCrossRefGoogle Scholar
  63. 63.
    Pallis AG, et al. EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Ann Oncol. 2011;22(8):1922–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Mohile S, Xian Y, Dale W, Fisher S, Rodin M, Morrow G, Neugut A, Hall W. Association of a cancer diagnosis with vulnerability and frail older Medicare beneficiaries. J Natl Cancer Inst. 2009;101:1206–15.PubMedCrossRefGoogle Scholar
  65. 65.
    Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Rodin MB. Maintaining functional status. Chapter 111. In: Sinclair AJ, Morley JE, Vellas B, editors. Principles and practice of geriatric medicine. 5th ed. London: Wiley; 2012.Google Scholar
  68. 68.
    Inouye SK, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340(9):669–76.PubMedCrossRefGoogle Scholar
  69. 69.
    McAlpine JN, et al. The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies. Gynecol Oncol. 2008;109(2):296–302.PubMedCrossRefGoogle Scholar
  70. 70.
    Flood KL, et al. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol. 2006;24(15):2298–303.PubMedCrossRefGoogle Scholar
  71. 71.
    Wimberger P, et al. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2006;100(2):300–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Petignat P, et al. Poorer survival of elderly patients with ovarian cancer: a population-based study. Surg Oncol. 2004;13(4):181–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24(15):2304–10.PubMedCrossRefGoogle Scholar
  74. 74.
    Ellis G, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011(7):CD006211.Google Scholar
  75. 75.
    Cohen HJ, Fuessner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med. 2002;346:905–12.PubMedCrossRefGoogle Scholar
  76. 76.
    Rao AV, Hsieh F, Fuessner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol Med Sci. 2005;60A(6):798–803.CrossRefGoogle Scholar
  77. 77.
    Rodin MB. Cancer patients admitted to nursing homes: what do we know? J Am Med Dir Assoc. 2008;9(3):149–56.PubMedCrossRefGoogle Scholar
  78. 78.
    Cicerchia M, et al. Geriatric syndromes in peri-operative elderly cancer patients. Surg Oncol. 2010;19(3):131–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Rodin MB, Mohile SG. Assessing decisional capacity in the elderly. Semin Oncol. 2008;35(6):625–32.PubMedCrossRefGoogle Scholar
  80. 80.
    Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55(3):241–52.PubMedCrossRefGoogle Scholar
  81. 81.
    Dow LA, Matsuyama RK, Ramakrishnan V, et al. Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol. 2010;28(2):299–304.PubMedCrossRefGoogle Scholar
  82. 82.
    Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA. 2009;302:741–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Rabow M, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med. 2004;164:83–91.PubMedCrossRefGoogle Scholar
  84. 84.
    Rummans T, Clark MM, Sloan JA, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. J Clin Oncol. 2006;24:635–42.PubMedCrossRefGoogle Scholar
  85. 85.
    Jordhoy MS, Fayers P, Loge JH, et al. Quality of life in palliative cancer care: results from a clustered randomized trial. J Clin Oncol. 2001;19:3884–94.PubMedGoogle Scholar
  86. 86.
    Allore HG, et al. Experimental designs for multicomponent interventions among persons with multifactorial geriatric syndromes. Clin Trials. 2005;2(1):13–21.PubMedCrossRefGoogle Scholar
  87. 87.
    Temel JS, Greer JA, Musikansky A, et al. Early palliative care for patients with metastatic ­non-small cell lung cancer. N Engl J Med. 2010;363:733–42.PubMedCrossRefGoogle Scholar
  88. 88.
    Gill T, Feinstein A. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619–26.PubMedCrossRefGoogle Scholar
  89. 89.
    Vadhan-Raj S, Trent J, Patel S, et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010;153:358–67.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Internal Medicine Division of Geriatrics and GerontologySt. Louis University Medical SchoolSt. LouisUSA

Personalised recommendations